Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis
Related Posts
Zhao K, Vignolle GA, Labus JS, Mayer EA, Vaughan A, Dy M, Vora P, Hung MW, Vossel K, Gill C, Del Rio D, Stanton C,[...]
It is with great enthusiasm that we announce that Gregory F. Sonnenberg, PhD, has accepted the appointment as director of the UCLA Center for Research[...]
Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]